Trade AstraZeneca PLC - USD - AZN CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.18 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023401% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001179% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 66.56 |
| Open | 65.99 |
| 1-Year Change | -0.38% |
| Day's Range | 65.96 - 66.35 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Dec 24, 2024 | 66.20 | 0.22 | 0.33% | 65.98 | 66.44 | 65.84 |
| Dec 23, 2024 | 66.56 | 0.80 | 1.22% | 65.76 | 66.67 | 65.51 |
| Dec 20, 2024 | 65.30 | 1.54 | 2.42% | 63.76 | 65.41 | 63.66 |
| Dec 19, 2024 | 64.36 | -0.09 | -0.14% | 64.45 | 64.79 | 64.24 |
| Dec 18, 2024 | 64.56 | -1.24 | -1.88% | 65.80 | 66.35 | 64.45 |
| Dec 17, 2024 | 67.13 | 0.64 | 0.96% | 66.49 | 67.41 | 66.46 |
| Dec 16, 2024 | 66.16 | -0.49 | -0.74% | 66.65 | 67.12 | 66.15 |
| Dec 13, 2024 | 66.50 | 0.02 | 0.03% | 66.48 | 66.64 | 66.08 |
| Dec 12, 2024 | 66.88 | 0.06 | 0.09% | 66.82 | 67.52 | 66.80 |
| Dec 11, 2024 | 67.33 | -0.09 | -0.13% | 67.42 | 67.68 | 67.14 |
| Dec 10, 2024 | 67.12 | -1.18 | -1.73% | 68.30 | 68.32 | 67.03 |
| Dec 9, 2024 | 68.53 | 0.62 | 0.91% | 67.91 | 68.94 | 67.88 |
| Dec 6, 2024 | 68.13 | 0.00 | 0.00% | 68.13 | 68.50 | 67.75 |
| Dec 5, 2024 | 67.47 | 0.26 | 0.39% | 67.21 | 67.95 | 67.18 |
| Dec 4, 2024 | 66.70 | -0.02 | -0.03% | 66.72 | 66.88 | 66.24 |
| Dec 3, 2024 | 67.98 | -0.50 | -0.73% | 68.48 | 68.59 | 67.95 |
| Dec 2, 2024 | 66.96 | -0.44 | -0.65% | 67.40 | 67.48 | 66.76 |
| Nov 29, 2024 | 67.54 | 0.38 | 0.57% | 67.16 | 67.65 | 67.08 |
| Nov 27, 2024 | 67.13 | 0.54 | 0.81% | 66.59 | 67.26 | 66.47 |
| Nov 26, 2024 | 66.18 | -0.37 | -0.56% | 66.55 | 66.72 | 65.82 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
AstraZeneca - USD Company profile
About AstraZeneca plc (ADR)
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, AstraZeneca plc (ADR) revenues increased 41% to $37.42B. Net income decreased 96% to $112M. Revenues reflect Farxiga segment increase of 53% to $3B, Calquenc segment increase from $522M to $1.24B, Tagrisso segment increase of 16% to $5.02B, United States segment increase of 35% to $12.05B, United Kingdom segment increase of 86% to $3.25B, Sweden segment increase from $1.03B to $2.32B.
Equity composition
Ordinary Shares $.25, 12/10, 2.4B auth. 1,409,023,452 issd.Insiders own 0.37%. 5/93, Company formed through spin-off of a wholly-owned subsidiary ICI Zeneca Limited. Basis: 1-for-1. *FY'01 Q's are restated for deferred tax. 07/15, 2-for-1, Stock Split.
| Industry: | Pharmaceuticals (NEC) |
1 Francis Crick Avenue
CAMBRIDGE
CAMBRIDGESHIRE CB2 0AA
GB
News
Pi Network coin price prediction: Third party price target
Discover the Pi Network coin price predictions for 2025 onward, with analyst outlooks, price targets and CFDs trading strategies on Capital.com
13:51, 13 December 2024
Euro forecast: third party data roundup
In 2024, the euro’s outlook appeared more stable. Read on for our 2025 and beyond insights.
22:39, 12 December 2024
Projected US interest rates in 5 years: Third party round up
As the US central bank starts its cutting cycle, what are the projected interest rates in 5 years?
14:28, 12 December 2024
Projected UK interest rates in 5 years
Bank of England (BoE) cut rates for the first time in August 2024, with further easing expected in the coming months. But how low are rates likely to go?
11:20, 12 December 2024
Dogecoin (DOGE) price prediction 2025-2030: Could Dogecoin reach $1? - Third party price target
We look at the meme coin’s price performance and the latest DOGE price predictions
08:37, 12 December 2024
Gold price predictions for the next five years: Third party data round up
Explore the future of gold prices and whether the yellow metal will continue its upward trend in the coming years.
09:13, 6 December 2024
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
12:47, 5 December 2024People also watch
Still looking for a broker you can trust?
Join the 660,000+ traders worldwide that chose to trade with Capital.com